Experiments for taxon Portieria hornemannii (TO BE DETERMINED)

Experiments (36 results)

Filters
Worktypes (13)
10
10
10
9
9
8
8
4
4
2
1
1
1
No match
Pharmacology (6)
10
5
3
2
1
15
No match
Compounds (18)
13
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
4
No match
Organisms (7)
15
9
4
3
2
2
1
No match
36 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
243945
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Portieria hornemannii (TO BE DETERMINED)
APAKAOCHTODENE B
706073
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
211130
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
OCTA-1-6-DIENE,3-(BROMO-METHYL)-7-METHYL-2-3-6-TRICHLORO:
211141
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Portieria hornemannii (TO BE DETERMINED)
HALOMON,DEHYDRO:
609884
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
609887
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
609890
PHARMACOLOGY OF COMPOUND - IN VIVO
BIOAVAILABILITY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
211127
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
HALOMON
491166
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
COT-1-ENE,6(R)-BROMO-3(S)-BROMO-METHYL-7-METHYL-2-3-7-TRICHLORO:
211136
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
CYCLOHEXANE,3-3-DIMETHYL: 6-BROMO-2-4-DICHLORO-1-(2-CHLORO-ETHENYL):
211138
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
CYCLOHEX-5-ENE,3-3-DIMETHYL: 2-4-DICHLORO-1-(2-CHLORO-ETHENYL):
211134
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
CYCLOHEX-1-ENE,3-3-DIMETHYL: 2-4-DIBROMO-1-(1-CHLORO-2'-BROMO-ETHYL):
211140
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
OCTA0-1-6-DIENE,3-(BROMO-METHYL)-7-METHYL-2-3-OICHLORO:
211125
ISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
211139
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
CYCLOHEX-5-ENE,3-3-DIMETHYL: 2-4-DICHLORO-1-(2-CHLORO-ETHENYL):
609888
PHARMACOLOGY OF COMPOUND - IN VIVO
BIOAVAILABILITY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
609885
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
243944
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Portieria hornemannii (TO BE DETERMINED)
APAKAOCHTODENE A
706070
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
211128
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Portieria hornemannii (TO BE DETERMINED)
HALOMON,ISO:
609882
PRESENT IN (REVIEW)
Portieria hornemannii (TO BE DETERMINED)
HALOMON
211129
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
HALOMON,ISO:
211133
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
OCTA-1-6-DIENE,6-BROMO-3-(BROMO-METHYL)-7-METHYL-2-3-DICHLORO:
211143
ISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
OCTA-1-6-DIENE,3-(BROMO-METHYL)-3-CHLORO-7-METHYL:CYCLOHEX-6-ENE,3-3-DIMETHYL: 4-BROMO-2-CHLORO-1-ETHENYL:MYRCENE,10-BROMO-7-CHLORO:
211132
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
OCTA-1-6-DIENE,6-BROMO-3-(BROMO-METHYL)-7-METHYL-2-3-DICHLORO:
706071
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
211131
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
OCTA-1-6-DIENE,3-(BROMO-METHYL)-7-METHYL-2-3-6-TRICHLORO:
706072
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
491167
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
COT-1-ENE,6(R)-BROMO-3(S)-BROMO-METHYL-7-METHYL-2-3-7-TRICHLORO:
211142
ISOLATION AND IDENTIFICATION OF
Portieria hornemannii (TO BE DETERMINED)
HALOMONCYCLOHEX-1-ENE,3-3-DIMETHYL: 2-4-DIBROMO-1-(1'-CHLORO-2'-BROMO-ETHYL):HALOMONON,ISO:OCTA-1-6-DIENE,6-BROMO-3-(BROMO-METHYL)-7-METHYL-2-3-DICHLORO:OCTA-1-6-DIENE,3-(BROMO-METHYL)-7-METHYL-2-3-6-TRICHLORO:
609889
PHARMACOLOGY OF COMPOUND - IN VIVO
BIOAVAILABILITY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
609883
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON
211137
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
CYCLOHEXANE,3-3-DIMETHYL: 6-BROMO-2-4-DICHLORO-1-(2-CHLORO-ETHENYL):
211126
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
HALOMON
211135
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Portieria hornemannii (TO BE DETERMINED)
CYCLOHEX-1-ENE,3-3-DIMETHYL: 2-4-DIBROMO-1-(1-CHLORO-2'-BROMO-ETHYL):
609886
PHARMACOLOGY OF COMPOUND - IN VIVO
PHARMACOKINETIC STUDY OF
Portieria hornemannii (TO BE DETERMINED)
HALOMON